A SURVEY ON DRUG UTILIZATION AND EVALUATION OF MEDICATION ADHERENCE IN OUTPATIENTS WITH TYPE 2 DIABETES AT TAM BINH DISTRICT MEDICAL CENTER, VINH LONG PROVINCE, IN 2025

Hồ Thế Phương Nguyễn, Thúy Hằng Hồ, Công Luận Trần, Thị Ngọc Mai Nguyễn

Main Article Content

Abstract

Introduction: Type 2 diabetes is a common non-communicable disease and a leading cause of morbidity and mortality. This study aims to analyze the use of medications and assess treatment adherence among outpatient type 2 diabetes patients at Tam Bình Health Center, Vĩnh Long Province, in 2025. Objectives: 1) To survey the situation of medication use for treating type 2 diabetes. 2) To determine the rate of adherence to treatment among type 2 diabetes. Methods: A descriptive cross-sectional study was conducted on 300 patients aged 18 and older who are receiving outpatient treatment for type 2 diabetes at Tam Bình Health Center, Vĩnh Long Province. Results: The study found that the most commonly used medication for type 2 diabetes was Metformin (42.33%), followed by Sulfonylurea (37.67%), Thiazolidinediones (11.33%), DPP-4 inhibitors (4.67%), and Incretin mimetics (4%). The majority of patients (62.67%) used fewer than 3 types of medications, with 96% using oral medications. Regarding treatment adherence, only 28% of patients adhered to their prescribed treatment, while 72% did not, indicating a significant challenge in managing type 2 diabetes. Statistically significant factors influencing adherence included education level (higher adherence with higher education) and comorbid conditions, particularly lipid metabolism disorders. Conclusions: The adherence rate to medication treatment for type 2 diabetes was only 28%, with a high proportion of non-adherence (72%). Recommendations include: 1) Conducting prospective studies to clearly assess the impact of non-adherence on patient health. 2) Strengthening health education and awareness programs to improve treatment adherence.

Article Details

References

J. A. Alshahrani, A. S. Alshahrani, A. M. Alshahrani, A. M. Alshalaan, M. N. Alhumam, N. Z. th Alshahrani (2023) "The Impact of Diabetes Mellitus Duration and Complications on Health-Related Quality of Life Among Type 2 Diabetic Patients in Khamis Mushit City, Saudi Arabia". Cureus, 15 (8), e44216.
2. X. H. Guo, L. N. Ji, J. M. Lu, J. Liu, Q. Q. Lou, J. Liu, et al. (2014) "Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment". J Diabetes, 6 (4), 290-7.
3. K. Heissam, Z. Abuamer, N. El-Dahshan (2015). "Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study". Pan Afr Med J, 20, 177.
4. International Diabetes Federation (2021). IDF Diabetes Atlas,
5. Y. M. Lee, P. R. Lin, H. K. Sia (2024). "Oral antidiabetic therapy versus early insulinization on glycemic control in newly diagnosed type 2 diabetes patients: a retrospective matched cohort study". Sci Rep, 14 (1), 15491.
6. K. Ogurtsova, J. D. da Rocha Fernandes, Y. Huang, U. Linnenkamp, L. Guariguata, N. H. Cho, et al. (2017) "IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040". Diabetes Res Clin Pract, 128, 40-50.
7. I. A. Sefah, A. Okotah, D. K. Afriyie, S. K. Amponsah (2020). "Adherence to Oral Hypoglycemic Drugs among Type 2 Diabetic Patients in a Resource-Poor Setting". Int J Appl Basic Med Res, 10 (2), 102-109.
8. R. Xu, M. Xing, K. Javaherian, R. Peters, W. Ross, C. Bernal-Mizrachi (2020). "Improving HbA(1c) with Glucose Self-Monitoring in Diabetic Patients with EpxDiabetes, a Phone Call and Text Message-Based Telemedicine Platform: A Randomized Controlled Trial". Telemed J E Health, 26 (6), 784-793.